Transcatheter mitral valve-in-valve replacement transeptally using a novel balloon-expandable device

Maria Drakopoulou; George Latsios; Andreas Synetos; Georgios Benetos; Stergios Soulaidopoulos; Georgios Oikonomou; Anastasios Apostolos; Konstantina Aggeli; Vasilios Lozos; Dimitrios Lymperiadis; Konstantinos Tsioufis; Konstantinos Toutouzas

doi:10.1111/jocs.16819

Transcatheter mitral valve-in-valve replacement transeptally using a novel balloon-expandable device

J Card Surg. 2022 Oct;37(10):3376-3377. doi: 10.1111/jocs.16819. Epub 2022 Aug 10.

Affiliation

¹ First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.

PMID: 35949139
DOI: 10.1111/jocs.16819

Abstract

We describe a patient with symptomatic severe mitral regurgitation, due to a failed 33-mm Epic (St. Jude Medical, St. Paul, MN) bioprosthetic heart valve surgically implanted 10-year before. For this specific purpose, we implanted a novel balloon-expandable transcatheter heart valve, the MyVal (Meril Life Science, Vapi, India). To the best of our knowledge, this is the second case describing the implantation of MyVal in a degenerative, surgically placed bioprosthesis.

Keywords: cardiovascular research; valve repair/replacement.

Publication types

Case Reports

MeSH terms

Bioprosthesis*
Heart Valve Prosthesis Implantation*
Heart Valve Prosthesis*
Humans
Mitral Valve / surgery
Prosthesis Design
Prosthesis Failure
Transcatheter Aortic Valve Replacement*
Treatment Outcome